Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity.

Kitcher SR, Kirkwood NK, Camci ED, Wu P, Gibson RM, Redila VA, Simon JA, Rubel EW, Raible DW, Richardson GP, Kros CJ.

JCI Insight. 2019 Aug 8;4(15). pii: 126764. doi: 10.1172/jci.insight.126764. eCollection 2019 Aug 8.

2.

What Is Your Neurologic Diagnosis?

Gibson RMB, Shores A, Cooley AJ.

J Am Vet Med Assoc. 2018 Sep 1;253(5):559-562. doi: 10.2460/javma.253.5.559. No abstract available.

PMID:
30110205
3.

Thrombolysis with tissue plasminogen activator (TPA) in feline acute aortic thromboembolism: a retrospective study of 16 cases.

Guillaumin J, Gibson RM, Goy-Thollot I, Bonagura JD.

J Feline Med Surg. 2019 Apr;21(4):340-346. doi: 10.1177/1098612X18778157. Epub 2018 May 29.

PMID:
29807505
4.

Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral Activity.

Paparisto E, Woods MW, Coleman MD, Moghadasi SA, Kochar DS, Tom SK, Kohio HP, Gibson RM, Rohringer TJ, Hunt NR, Di Gravio EJ, Zhang JY, Tian M, Gao Y, Arts EJ, Barr SD.

J Virol. 2018 Jun 13;92(13). pii: e00528-18. doi: 10.1128/JVI.00528-18. Print 2018 Jul 1.

5.

Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda.

Ndashimye E, Avino M, Kyeyune F, Nankya I, Gibson RM, Nabulime E, Poon AFY, Kityo C, Mugyenyi P, Quiñones-Mateu ME, Arts EJ.

AIDS Res Hum Retroviruses. 2018 May;34(5):404-414. doi: 10.1089/AID.2017.0205. Epub 2018 Feb 26.

6.

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.

Gibson RM, Nickel G, Crawford M, Kyeyune F, Venner C, Nankya I, Nabulime E, Ndashimye E, Poon AFY, Salata RA, Kityo C, Mugyenyi P, Quiñones-Mateu ME, Arts EJ.

Infect Dis Poverty. 2017 Dec 4;6(1):163. doi: 10.1186/s40249-017-0377-0.

7.

Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.

Weber J, Gibson RM, Sácká L, Strunin D, Hodek J, Weberová J, Pávová M, Alouani DJ, Asaad R, Rodriguez B, Lederman MM, Quiñones-Mateu ME.

AIDS Res Ther. 2017 Mar 20;14:15. doi: 10.1186/s12981-017-0144-0. eCollection 2017.

8.

Electroencephalographic Recordings During Withdrawal of Life-Sustaining Therapy Until 30 Minutes After Declaration of Death.

Norton L, Gibson RM, Gofton T, Benson C, Dhanani S, Shemie SD, Hornby L, Ward R, Young GB.

Can J Neurol Sci. 2017 Mar;44(2):139-145. doi: 10.1017/cjn.2016.309.

PMID:
28231862
9.

Reply.

Gibson RM, Chennu S, Fernández-Espejo D, Naci L, Owen AM, Cruse D.

Ann Neurol. 2017 Jan;81(1):160-161. doi: 10.1002/ana.24827. Epub 2016 Dec 28. No abstract available.

PMID:
27873348
10.

A hierarchy of event-related potential markers of auditory processing in disorders of consciousness.

Beukema S, Gonzalez-Lara LE, Finoia P, Kamau E, Allanson J, Chennu S, Gibson RM, Pickard JD, Owen AM, Cruse D.

Neuroimage Clin. 2016 Aug 4;12:359-71. doi: 10.1016/j.nicl.2016.08.003. eCollection 2016.

11.

Brain-computer interfaces for patients with disorders of consciousness.

Gibson RM, Owen AM, Cruse D.

Prog Brain Res. 2016;228:241-91. doi: 10.1016/bs.pbr.2016.04.003. Epub 2016 May 10. Review.

PMID:
27590972
12.

Somatosensory attention identifies both overt and covert awareness in disorders of consciousness.

Gibson RM, Chennu S, Fernández-Espejo D, Naci L, Owen AM, Cruse D.

Ann Neurol. 2016 Sep;80(3):412-23. doi: 10.1002/ana.24726. Epub 2016 Aug 4.

PMID:
27422169
13.

Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis.

Li Q, Karim AF, Ding X, Das B, Dobrowolski C, Gibson RM, Quiñones-Mateu ME, Karn J, Rojas RE.

Sci Rep. 2016 Jun 14;6:27566. doi: 10.1038/srep27566.

14.

Progression from Vegetative to Minimally Conscious State Is Associated with Changes in Brain Neural Response to Passive Tasks: A Longitudinal Single-Case Functional MRI Study.

Tomaiuolo F, Cecchetti L, Gibson RM, Logi F, Owen AM, Malasoma F, Cozza S, Pietrini P, Ricciardi E.

J Int Neuropsychol Soc. 2016 Jul;22(6):620-30. doi: 10.1017/S1355617716000485. Epub 2016 Jun 6.

PMID:
27264964
15.

Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.

Kyeyune F, Gibson RM, Nankya I, Venner C, Metha S, Akao J, Ndashimye E, Kityo CM, Salata RA, Mugyenyi P, Arts EJ, Quiñones-Mateu ME.

Antimicrob Agents Chemother. 2016 May 23;60(6):3380-97. doi: 10.1128/AAC.00038-16. Print 2016 Jun.

16.

Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing.

Virk SM, Gibson RM, Quinones-Mateu ME, Barnholtz-Sloan JS.

PLoS One. 2015 May 7;10(5):e0124178. doi: 10.1371/journal.pone.0124178. eCollection 2015.

17.

Multiple tasks and neuroimaging modalities increase the likelihood of detecting covert awareness in patients with disorders of consciousness.

Gibson RM, Fernández-Espejo D, Gonzalez-Lara LE, Kwan BY, Lee DH, Owen AM, Cruse D.

Front Hum Neurosci. 2014 Nov 26;8:950. doi: 10.3389/fnhum.2014.00950. eCollection 2014.

18.

Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy.

Gibson RM, Weber J, Winner D, Miller MD, Quiñones-Mateu ME.

PLoS One. 2014 Aug 11;9(8):e104512. doi: 10.1371/journal.pone.0104512. eCollection 2014.

19.

Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?

Gibson RM, Schmotzer CL, Quiñones-Mateu ME.

Curr Infect Dis Rep. 2014 Apr;16(4):401. doi: 10.1007/s11908-014-0401-5.

PMID:
24585216
20.

Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.

Gibson RM, Meyer AM, Winner D, Archer J, Feyertag F, Ruiz-Mateos E, Leal M, Robertson DL, Schmotzer CL, Quiñones-Mateu ME.

Antimicrob Agents Chemother. 2014;58(4):2167-85. doi: 10.1128/AAC.02710-13. Epub 2014 Jan 27.

21.

Complexity and familiarity enhance single-trial detectability of imagined movements with electroencephalography.

Gibson RM, Chennu S, Owen AM, Cruse D.

Clin Neurophysiol. 2014 Aug;125(8):1556-67. doi: 10.1016/j.clinph.2013.11.034. Epub 2013 Dec 13.

PMID:
24388403
22.

Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

Weber J, Vazquez AC, Winner D, Gibson RM, Rhea AM, Rose JD, Wylie D, Henry K, Wright A, King K, Archer J, Poveda E, Soriano V, Robertson DL, Olivo PD, Arts EJ, Quiñones-Mateu ME.

J Clin Microbiol. 2013 May;51(5):1517-27. doi: 10.1128/JCM.00092-13. Epub 2013 Mar 13.

23.

Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study.

Prieto P, Cole T, Curren R, Gibson RM, Liebsch M, Raabe H, Tuomainen AM, Whelan M, Kinsner-Ovaskainen A.

Regul Toxicol Pharmacol. 2013 Apr;65(3):344-65. doi: 10.1016/j.yrtph.2012.11.013. Epub 2012 Dec 13.

PMID:
23246604
24.

Past, present, and future of entry inhibitors as HIV microbicides.

Gibson RM, Arts EJ.

Curr HIV Res. 2012 Jan 1;10(1):19-26. Review.

PMID:
22264042
25.

What are we reading now? An update on the papers published in the orthodontic literature (1999-2008).

Gibson RM, Harrison JE.

J Orthod. 2011 Sep;38(3):196-207. doi: 10.1179/14653121141461.

PMID:
21875993
26.

Exposure-driven risk assessment: applying exposure-based waiving of toxicity tests under REACH.

Rowbotham AL, Gibson RM.

Food Chem Toxicol. 2011 Aug;49(8):1661-73. doi: 10.1016/j.fct.2011.03.050. Epub 2011 Mar 30. Review.

PMID:
21458516
27.

A novel yeast-based recombination method to clone and propagate diverse HIV-1 isolates.

Dudley DM, Gao Y, Nelson KN, Henry KR, Nankya I, Gibson RM, Arts EJ.

Biotechniques. 2009 May;46(6):458-67. doi: 10.2144/000113119.

28.

Transport of interleukin-1 across cerebromicrovascular endothelial cells.

Skinner RA, Gibson RM, Rothwell NJ, Pinteaux E, Penny JI.

Br J Pharmacol. 2009 Apr;156(7):1115-23. doi: 10.1111/j.1476-5381.2008.00129.x. Epub 2009 Mar 4.

29.

A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat.

Ross J, Brough D, Gibson RM, Loddick SA, Rothwell NJ.

Neuropharmacology. 2007 Oct;53(5):638-42. Epub 2007 Aug 10.

PMID:
17845807
30.

Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells.

Arboleda G, Huang TJ, Waters C, Verkhratsky A, Fernyhough P, Gibson RM.

Eur J Neurosci. 2007 May;25(10):3030-8.

PMID:
17561816
32.

The effects of antihypertensive medication on dental treatment.

Gibson RM, Meechan JG.

Dent Update. 2007 Mar;34(2):70-2, 75-6, 78.

PMID:
17432770
33.

Integrin-binding RGD peptides induce rapid intracellular calcium increases and MAPK signaling in cortical neurons.

Watson PM, Humphries MJ, Relton J, Rothwell NJ, Verkhratsky A, Gibson RM.

Mol Cell Neurosci. 2007 Feb;34(2):147-54. Epub 2006 Dec 5.

PMID:
17150373
34.

Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release.

Thornton P, Pinteaux E, Gibson RM, Allan SM, Rothwell NJ.

J Neurochem. 2006 Jul;98(1):258-66.

35.

The role of inflammation in CNS injury and disease.

Lucas SM, Rothwell NJ, Gibson RM.

Br J Pharmacol. 2006 Jan;147 Suppl 1:S232-40. Review.

36.

Microsatellite DNA analysis shows that greater sage grouse leks are not kin groups.

Gibson RM, Pires D, Delaney KS, Wayne RK.

Mol Ecol. 2005 Dec;14(14):4453-9.

PMID:
16313605
37.

Metabolic activity: a novel indicator of neuronal survival in the murine dopaminergic cell line CAD.

Arboleda G, Waters C, Gibson RM.

J Mol Neurosci. 2005;27(1):65-77.

PMID:
16055947
38.

Calmodulin-dependent protein kinases phosphorylate gp130 at the serine-based dileucine internalization motif.

Gibson RM, Laszlo GS, Nathanson NM.

Biochim Biophys Acta. 2005 Aug 1;1714(1):56-62.

39.

Activation of integrin alpha5beta1 delays apoptosis of Ntera2 neuronal cells.

Gibson RM, Craig SE, Heenan L, Tournier C, Humphries MJ.

Mol Cell Neurosci. 2005 Mar;28(3):588-98.

PMID:
15737747
40.

Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling.

Molina-Holgado F, Pinteaux E, Heenan L, Moore JD, Rothwell NJ, Gibson RM.

Mol Cell Neurosci. 2005 Jan;28(1):189-94.

PMID:
15607953
41.

An activating mutant of Cdc42 that fails to interact with Rho GDP-dissociation inhibitor localizes to the plasma membrane and mediates actin reorganization.

Gibson RM, Gandhi PN, Tong X, Miyoshi J, Takai Y, Konieczkowski M, Sedor JR, Wilson-Delfosse AL.

Exp Cell Res. 2004 Dec 10;301(2):211-22.

PMID:
15530857
42.

CNS injury: the role of the cytokine IL-1.

Gibson RM, Rothwell NJ, Le Feuvre RA.

Vet J. 2004 Nov;168(3):230-7. Review.

PMID:
15501140
43.

Report of the Working Groups on Breast MRI: report of the Biopsy and Intervention Working Group.

Klimberg VS, Henry-Tillman R, Julian TB, Robinson D, Smith DM, Mark J, Schubert T, Oslan A, Gibson RM, Harms SE.

Breast J. 2004 Sep-Oct;10 Suppl 2:S13-6. No abstract available.

PMID:
15330875
44.

An activating mutant of Rac1 that fails to interact with Rho GDP-dissociation inhibitor stimulates membrane ruffling in mammalian cells.

Gandhi PN, Gibson RM, Tong X, Miyoshi J, Takai Y, Konieczkowski M, Sedor JR, Wilson-Delfosse AL.

Biochem J. 2004 Mar 1;378(Pt 2):409-19.

45.

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

Molina-Holgado F, Pinteaux E, Moore JD, Molina-Holgado E, Guaza C, Gibson RM, Rothwell NJ.

J Neurosci. 2003 Jul 23;23(16):6470-4.

46.

Active formation of mixed-species grouse leks: a role for predation in lek evolution?

Gibson RM, Aspbury AS, McDaniel LL.

Proc Biol Sci. 2002 Dec 22;269(1509):2503-7.

47.

Recent population trends in nonmetropolitan cities and villages: from the turnaround, through reversal, to the rebound.

Fuguitt GV, Beale CL, Fulton JA, Gibson RM.

Res Rural Sociol Dev. 1998;7:1-21.

PMID:
12294791
48.

Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent.

Moore JD, Rothwell NJ, Gibson RM.

Br J Pharmacol. 2002 Feb;135(4):1069-77.

50.

Microsatellite analysis of female mating behaviour in lek-breeding sage grouse.

Semple K, Wayne RK, Gibson RM.

Mol Ecol. 2001 Aug;10(8):2043-8. Erratum in: Mol Ecol 2002 Jan;11(1):153.

PMID:
11555247

Supplemental Content

Loading ...
Support Center